glp-1 agonist Frontiers GLP1 agonists: current and future
Description
PLoS ONE 18(1):e0278685 Ferhatbegovi L, Mri D, Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases
[DOI] [Google Scholar] 63.Zhou L., Li Y., He W., et al
Sie ermglicht es, ber gezielte Muskeltests funktionelle Strungen im Krper aufzudecken, die mit klassischen Laborwerten oft nicht sichtbar werden
Trial results vary by drug, dose, baseline weight, adherence, side-effect tolerance, and whether patients can stay on treatment
[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Lu G., Wang Y., Shi Y., Zhang Z., Huang C., He W., Wang C., Shen H.M
52 These results, in part, supported the development of orforglipron as an orally delivered GLP-1RA in clinical testing
